Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Société des Produits Nestlé (SPN)
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy newborn singleton infant
Full-term (\>= 37 weeks gestation)
Birth weight between \>= 2500 and \< =4500 g
14 ± 3 days of age on enrollment
Infant's mother has elected not to breastfeed
baby has been exclusively formula fed a minimum of 3 days prior to enrollment
Study explained and written information provided with Parent/Caregiver
Informed consent signed (parent/legal representative)
You may not be if
Congenital illness or malformation affecting infant feeding and/or growth
Suspected or known allergy to cow's milk protein
Significant pre-natal and/or post-natal disease
Any readmission to hospital (except for hyperbilirubinemia) prior to enrollment
Infant has received oral or IV antibiotic therapy in the 10 days prior to enrollment
Infant receiving prescription medication (with exception of topical antibiotics and/or treatment for thrush) or frequent use of over the counter medications except vitamin and mineral supplements
Infant has received probiotics in the seven days prior to enrollment
Infant currently participating in another clinical study
Infant's family who in the Investigator's assessment cannot be expected to comply with the protocol
Clareo Health | Growth of Infants Fed an Extensively Hydrolyzed Infant Formula